---
$id: https://graph.org.ai/products/commodity/51332810
$type: Product
source: UNSPSC
code: "51332810"
title: "Cyamemazine"
class: "51332800"
classTitle: "Antipsychotic phenothiazines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyamemazine

**UNSPSC Code**: 51332810
**Class**: [Antipsychotic phenothiazines](Antipsychotic phenothiazines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H21N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A2JGV5CNU4, chemically known as 10h-phenothiazine-2-carbonitrile, 10-(3-(dimethylamino)-2-methylpropyl)- (9ci) but generally known as cyamemazine, which bears US NIH Compound Identifier 62865. European Medicines Agency schedules Cyamemazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06836MIG. The term CYAMEMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules cyamemazine in its Anatomical Therapeutic Chemical (ATC) Classification. CYAMEMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyamemazine under HS 29343090 and SITC 51578. As of Q4 2014, CYAMEMAZINE remains the US FDA Preferred Term for this commodity. Cyamemazine bears US NLM identifiers UMLS ID C0056643 and NCI Concept Code C79120. SMILES: S1C2C(N(CC(CN(C)C)C)C3C1CCCC3)CC(CC2)C#N.

